本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ARS PHARMACEUTICALS INC

4.14
-0.0150-0.36%
成交量:39.30萬
成交額:162.42萬
市值:4.11億
市盈率:-1.90
高:4.20
開:4.10
低:4.10
收:4.15
52周最高:13.15
52周最低:4.10
股本:9,944.73萬
流通股本:4,803.45萬
量比:0.37
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.1757
每股收益(LYR):-1.7400
淨資產收益率:-210.35%
總資產收益率:-48.02%
市淨率:32.87
市盈率(LYR):-2.38

資料載入中...

2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/06

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report